 |
PDBsum entry 4w1v
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
4w1v
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Target-Based identification of whole-Cell active inhibitors of biotin biosynthesis in mycobacterium tuberculosis.
|
 |
|
Authors
|
 |
S.W.Park,
D.E.Casalena,
D.J.Wilson,
R.Dai,
P.P.Nag,
F.Liu,
J.P.Boyce,
J.A.Bittker,
S.L.Schreiber,
B.C.Finzel,
D.Schnappinger,
C.C.Aldrich.
|
 |
|
Ref.
|
 |
Chem Biol, 2015,
22,
76-86.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Biotin biosynthesis is essential for survival and persistence of Mycobacterium
tuberculosis (Mtb) in vivo. The aminotransferase BioA, which catalyzes the
antepenultimate step in the biotin pathway, has been established as a promising
target due to its vulnerability to chemical inhibition. We performed
high-throughput screening (HTS) employing a fluorescence displacement assay and
identified a diverse set of potent inhibitors including many diversity-oriented
synthesis (DOS) scaffolds. To efficiently select only hits targeting biotin
biosynthesis, we then deployed a whole-cell counterscreen in biotin-free and
biotin-containing medium against wild-type Mtb and in parallel with isogenic
bioA Mtb strains that possess differential levels of BioA expression. This
counterscreen proved crucial to filter out compounds whose whole-cell activity
was off target as well as identify hits with weak, but measurable whole-cell
activity in BioA-depleted strains. Several of the most promising hits were
cocrystallized with BioA to provide a framework for future structure-based drug
design efforts.
|
 |
|
|
|
|
 |